ENDRA Life Sciences Inc.
NDRA
$6.46
$1.1922.58%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -5.92M | -7.30M | -7.03M | -8.01M | -8.77M |
| Total Depreciation and Amortization | 157.80K | 151.40K | 157.30K | 164.20K | 178.80K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 502.00K | 1.70M | 1.67M | 2.49M | 2.95M |
| Change in Net Operating Assets | 434.10K | 439.20K | 22.70K | 267.60K | 56.10K |
| Cash from Operations | -4.82M | -5.01M | -5.18M | -5.09M | -5.58M |
| Capital Expenditure | -18.70K | 0.00 | -17.30K | -17.30K | -17.30K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | 0.00 | 0.00 |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -314.20K | -2.55M | -3.00M | -- | -- |
| Cash from Investing | -332.90K | -2.55M | -3.02M | -17.30K | -17.30K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | 0.00 | 0.00 |
| Issuance of Common Stock | 8.89M | 5.85M | 5.73M | 2.47M | 2.32M |
| Repurchase of Common Stock | -- | -- | -- | -- | -1.32M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -1.32M | 0.00 |
| Cash from Financing | 8.89M | 5.85M | 5.73M | 1.15M | 1.00M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | 0.00 | 0.00 |
| Net Change in Cash | 3.73M | -1.71M | -2.47M | -3.95M | -4.59M |